Why an Alternative to Blood Transfusion?

Critical Care Clinics

Volumn 25, Issue 2, 2009, Pages 261-277

  Shander, Aryeh ^a,b   Goodnough, Lawrence Tim ^c  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; Complication; Cost; Outcome; Risk; Transfusion

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN;

ANEMIA; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD COMPATIBILITY; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL RESEARCH; COST BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFECTION RISK; OUTCOME ASSESSMENT; OXYGEN AFFINITY; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW;

BLOOD DONORS; BLOOD PHYSIOLOGICAL PROCESSES; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; HUMANS; RISK FACTORS;

EID: 63049113257     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.12.012     Document Type: Review

References (102)

1. Alberts B., Johnson A., Lewis J., et al. Molecular biology of the cell. 4th edition (2002), Garland Science, New York p. 3-45
2. Hardison R.C. A brief history of hemoglobins: plant, animal, protist, and bacteria. Proc Natl Acad Sci U S A 93 12 (1996) 5675-5679
3. Shander A. Anemia in the critically ill. Crit Care Clin 20 2 (2004) 159-178
4. Madjdpour C., Spahn D.R., and Weiskopf R.B. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med 34 Suppl 5 (2006) S102-S108
5. Marshall J.C. Transfusion trigger: when to transfuse?. Crit Care 8 Suppl 2 (2004) S31-S33
6. Weiskopf R.B., Viele M.K., Feiner J., et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279 3 (1998) 217-221
7. Fowler N.O., and Holmes J.C. Blood viscosity and cardiac output in acute experimental anemia. J Appl Physiol 39 3 (1975) 453-456
8. Habler O.P., Kleen M.S., Podtschaske A.H., et al. The effect of acute normovolemic hemodilution (ANH) on myocardial contractility in anesthetized dogs. Anesth Analg 83 3 (1996) 451-458
9. Barbee J.H., and Cokelet G.R. The Fahraeus effect. Microvasc Res 3 1 (1971) 6-16
10. Chapler C.K., and Cain S.M. The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution. Can J Physiol Pharmacol 64 1 (1986) 7-12
11. Morisaki H., and Sibbald W.J. Tissue oxygen delivery and the microcirculation. Crit Care Clin 20 2 (2004) 213-223
12. Hebert P.C., Van der Linden P., Biro G., et al. Physiologic aspects of anemia. Crit Care Clin 20 2 (2004) 187-212
13. van Bommel J., Siegemund M., Henny C., et al. Heart, kidney, and intestine have different tolerances for anemia. Transl Res 151 2 (2008) 110-117
14. Cabrales P., Tsai A.G., and Intaglietta M. Is resuscitation from hemorrhagic shock limited by blood oxygen-carrying capacity or blood viscosity?. Shock 27 4 (2007) 380-389
15. Ickx B.E., Rigolet M., and Van Der Linden P.J. Cardiovascular and metabolic response to acute normovolemic anemia. Effects of anesthesia. Anesthesiology 93 4 (2000) 1011-1016
16. Spahn D.R., Seifert B., Pasch T., et al. Haemodilution tolerance in patients with mitral regurgitation. Anaesthesia 53 1 (1998) 20-24
17. Roseberg B., and Wulff K. Hemodynamics following normovolemic hemodilution in elderly patients. Acta Anaesthesiol Scand 25 5 (1981) 402-406
18. Murphy G.J., Reeves B.C., Rogers C.A., et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116 22 (2007) 2544-2552
19. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 13 (2004) 1555-1562
20. Gerber D.R. Transfusion of packed red blood cells in patients with ischemic heart disease. Crit Care Med 36 4 (2008) 1068-1074
21. Jani S.M., Smith D.E., Share D., et al. Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention. Clin Cardiol 30 10 Suppl 2 (2007) II49-II56
22. Madjdpour C., Heindl V., and Spahn D.R. Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol 72 5 (2006) 283-298
23. Hébert P.C., McDonald B.J., and Tinmouth A. Clinical consequences of anemia and red cell transfusion in the critically ill. Crit Care Clin 20 2 (2004) 225-235
24. Goodnough L.T. Transfusion triggers. Surgery 142 Suppl 4 (2007) S67-S70
25. Shander A., and Goodnough L.T. Update on transfusion medicine. Pharmacotherapy 27 9 Pt 2 (2007) 57S-68S
26. Dodd R.Y. Current risk for transfusion transmitted infections. Curr Opin Hematol 14 6 (2007) 671-676
27. Becker J.L. Vector-borne illnesses and the safety of the blood supply. Curr Hematol Rep 2 6 (2003) 511-517
28. Arguin P.M., Singleton J., Rotz L.D., et al. An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion-Associated Tick-Borne Illness Task Force. Transfusion 39 8 (1999) 828-833
29. Shander A. Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 41 1 Suppl 1 (2004) 117-124
30. Klein H.G. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 257 3 (2005) 224-237
31. Webert K.E., Cserti C.M., Hannon J., et al. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 22 1 (2008) 1-34
32. Busch M.P., Kleinman S.H., and Nemo G.J. Current and emerging infectious risks of blood transfusions. JAMA 289 8 (2003) 959-962
33. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 20074;370(9585):415-426.
34. Brown P. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 13 Suppl 5 (2007) 33-40
35. Goodnough L.T., Brecher M.E., Kanter M.H., et al. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 340 6 (1999) 438-447
36. Editorial team. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 200718;12(1):E070118.4
37. Wagner S.J. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 86 3 (2004) 157-163
38. Kleinman S., Chan P., and Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 17 2 (2003) 120-162
39. Canadian Paediatric Society. Transfusion and risk of infection in Canada: Update 2006. Can J Infect Dis Med Microbiol 17 2 (2006) 103-107
40. Cervia J.S., Wenz B., and Ortolano G.A. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients. Clin Infect Dis 45 8 (2007) 1008-1013
41. Schreiber G.B., Busch M.P., Kleinman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334 26 (1996) 1685-1690
42. Shander A., and Popovsky M.A. Understanding the consequences of transfusion-related acute lung injury. Chest 128 5 Suppl 2 (2005) 598S-604S
43. Waanders M.M., Roelen D.L., Brand A., et al. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Transfus Med Rev 19 4 (2005) 281-287
44. Goodnough L.T. Risks of blood transfusion. Anesthesiol Clin North America 23 2 (2005) 241-252 v
45. Goodnough L.T. Risks of blood transfusion. Crit Care Med 31 12 Suppl (2003) S678-S686
46. Bauer M.P., Wiersum-Osselton J., Schipperus M., et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 47 11 (2007) 2066-2071
47. Klein H.G., Spahn D.R., and Carson J.L. Red blood cell transfusion in clinical practice. Lancet 370 9585 (2007) 415-426
48. Anderson K. Broadening the spectrum of patient groups at risk for transfusion-associated GVHD: implications for universal irradiation of cellular blood components. Transfusion 43 12 (2003) 1652-1654
49. Linden J.V., Paul B., and Dressler K.P. A report of 104 transfusion errors in New York State. Transfusion 32 7 (1992) 601-606
50. Skeate R.C., and Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol 14 6 (2007) 682-687
51. King K.E., Shirey R.S., Thoman S.K., et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 44 1 (2004) 25-29
52. Tinmouth A., Fergusson D., Yee I.C., et al. ABLE Investigators; Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion 46 11 (2006) 2014-2027
53. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., et al. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion 47 7 (2007) 1212-1220
54. Ho J., Sibbald W.J., and Chin-Yee I.H. Effects of storage on efficacy of red cell transfusion: when is it not safe?. Crit Care Med 31 12 Suppl (2003) S687-S697
55. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 12 (2008) 1229-1239
56. Eder A.F., Hillyer C.D., Dy B.A., et al. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 299 19 (2008) 2279-2286
57. Leal-Noval S.R., Rincón-Ferrari M.D., García-Curiel A., et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 119 5 (2001) 1461-1468
58. Chelemer S.B., Prato B.S., Cox Jr. P.M., et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 73 1 (2002) 138-142
59. Engoren M.C., Habib R.H., Zacharias A., et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74 4 (2002) 1180-1186
60. Koch C.G., Li L., Van Wagoner D.R., et al. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 82 5 (2006) 1747-1756
61. Koch C.G., Li L., Duncan A.I., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 6 (2006) 1608-1616
62. Koch C.G., Li L., Duncan A.I., et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 81 5 (2006) 1650-1657
63. Chang H., Hall G.A., Geerts W.H., et al. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang 78 1 (2000) 13-18
64. Vincent J.L., Baron J.F., Reinhart K., et al. ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 288 12 (2002) 1499-1507
65. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32 1 (2004) 39-52
66. Gong M.N., Thompson B.T., Williams P., et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33 6 (2005) 1191-1198
67. Shorr A.F., Jackson W.L., Kelly K.M., et al. Transfusion practice and blood stream infections in critically ill patients. Chest 127 5 (2005) 1722-1728
68. Taylor R.W., O'Brien J., Trottier S.J., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 34 9 (2006) 2302-2308
69. Zilberberg M.D., Carter C., Lefebvre P., et al. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care 11 3 (2007) R63
70. Zilberberg M.D., Stern L.S., Wiederkehr D.P., et al. Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study. Crit Care 12 2 (2008) R60
71. Wu W.C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 17 (2001) 1230-1236
72. Carson J.L., Altman D.G., Duff A., et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 39 7 (1999) 694-700
73. nnerhofer P., Klingler A., Klimmer C., et al. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 45 1 (2005) 103-110
74. Weber E.W., Slappendel R., Prins M.H., et al. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg 100 5 (2005) 1416-1421
75. Smith M.J., Le Roux P.D., Elliott J.P., et al. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 101 1 (2004) 1-7
76. Claridge J.A., Sawyer R.G., Schulman A.M., et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 68 7 (2002) 566-572
77. Malone D.L., Dunne J., Tracy J.K., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54 5 (2003) 898-905 discussion 905-7
78. Dunne J.R., Malone D.L., Tracy J.K., et al. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt) 5 4 (2004) 395-404
79. Silverboard H., Aisiku I., Martin G.S., et al. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma 59 3 (2005) 717-723
80. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340 6 (1999) 409-417
81. Lacroix J., Hébert P.C., Hutchison J.S., et al. TRIPICU Investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356 16 (2007) 1609-1619
82. Goodnough L.T., and Bach R.G. Anemia, transfusion, and mortality. N Engl J Med 345 17 (2001) 1272-1274
83. Participant of the Cost of Blood Consensus Conference, Charleston, SC, May 4-5, 2003. The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfus Med Rev 19 1 (2005) 66-78
84. Shander A., Hofmann A., Gombotz H., et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 21 2 (2007) 271-289
85. Etchason J., Petz L., Keeler E., et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 332 11 (1995) 719-724
86. Crémieux P.Y., Barrett B., Anderson K., et al. Cost of outpatient blood transfusion in cancer patients. J Clin Oncol 18 14 (2000) 2755-2761
87. Marshall D.A., Kleinman S.H., Wong J.B., et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 86 1 (2004) 28-40
88. Shander A. Financial and clinical outcomes associated with surgical bleeding complications. Surgery 142 4 Suppl (2007) S20-S25
89. Whitaker BI, Sullivan M, Henry R, United States Department of Health and Human Services. The 2005 Nationwide Blood Collection and Utilization Survey Report. 2005 [cited 05-29-2008]. Available at: http://www.hhs.gov/bloodsafety/2005NBCUS.pdf.
90. World Health Organization, Twenty-Eighth World Health Assembly, Geneva, 13-30 May 1975:WHA28.72 Utilization and Supply of Human Blood and Blood Products, World Health Organization, Geneva, 1975 [cited 05-29-2008]. Available at: http://www.who.int/bloodsafety/en/WHA28.72.pdf.
91. Riley W., Schwei M., and McCullough J. The United States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion 47 7 (2007) 1180-1188
92. Sullivan M.T., Cotten R., Read E.J., et al. Blood collection and transfusion in the United States in 2001. Transfusion 47 3 (2007) 385-394
93. Zou S., Musavi F., Notari IV E.P., et al. ARCNET Research Group. Changing age distribution of the blood donor population in the United States. Transfusion 48 2 (2008) 251-257
94. Dann E.J., Bonstein L., Arbov L., et al. Blood bank protocols for large-scale civilian casualty events: experience from terrorist bombing in Israel. Transfus Med 17 2 (2007) 135-139
95. Sandler SG, Ouellette GJ. Transportation and other blood system issues related to disasters: Washington, DC experience of September 11, 2002. Vox Sang 2002;83(Suppl 1):367-70.
96. Spinella P.C., Perkins J.G., Grathwohl K.W., et al. 31st Combat Support Hospital Research Working Group. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med 35 11 (2007) 2576-2581
97. World Health Organization. Global Consultation on Universal Access to Safe Blood Transfusion. 9-11 June 2007, Ottawa, Canada [cited 05-29-2008]. Available at: http://www.who.int/bloodsafety/publications/Report_Global_Consultation_Ottawa_2007.pdf.
98. Goodnough L.T., Shander A., and Brecher M.E. Transfusion medicine: looking to the future. Lancet 361 9352 (2003) 161-169
99. Bates I., Manyasi G., and Medina Lara A. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability. Transfus Med 17 6 (2007) 434-442
100. World Health Organization. Global Database on Blood Safety Summary Report 2001-2. Geneva (2004). http://www.who.int/bloodsafety/GDBS_Report_2001-2002.pdf [cited 05-29-2008]. Available at
101. Gohel M.S., Bulbulia R.A., Slim F.J., et al. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl 87 1 (2005) 3-14
102. Goodnough L.T., Shander A., Spivak J.L., et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 101 6 (2005) 1858-1861